| [1] |
Chlenski A, Cohn SL. Modulation of matrix remodeling by SPARC in neoplastic progression[J]. Semin Cell Dev Biol, 2010, 21(1): 55 -65.
|
| [2] |
Nagaraju GP, Dontula R, El-Rayes BF, et al. Molecular mechanisms underlying the divergent roles of SPARC in human carcinogenesis[J]. Carcinogenesis, 2014, 35(5): 967-73.
|
| [3] |
Nagaraju GP, Sharma D. Anti-cancer role of SPARC, an inhibitor of adipogenesis[J]. Cancer Treat Rev, 2011, 37(7): 559-66.
|
| [4] |
Che YQ, Wang H, Qi J, et al. The analysis of the SPARC protein expression and clinical significance in esophageal squamous cell carcinoma[J]. Zhongguo Zhong Liu Lin Chuang, 2006, 33(2): 61 -3. [车轶群, 王海, 齐军, 等. 食管鳞癌组织中SPARC蛋白表 达的临床意义[J]. 中国肿瘤临床, 2006, 33(2): 61-3.]
|
| [5] |
Yang XG, Jiang C, Liu F, et al. SPARC protein expression and clinical significance in esophageal squamous cell carcinoma[J]. Zhong Liu Fang Zhi Yan Jiu, 2012, 39(10): 1240-2. [杨锡贵, 姜 超, 刘封, 等. SPARC 蛋白在食管鳞癌组织中的表达及临床意 义[J] 肿瘤防治研究, 2012, 39(10): 1240-2.]
|
| [6] |
Yang XG, Giang C, Liu F, et al. The relationship between SPARC protein expression and the survival in esophageal squamous cell carcinoma[J]. Zhonghua Xiao Hua Za Zhi, 2013, 33(3): 197-8. [杨 锡贵, 姜超, 刘封, 等. 食管鳞状细胞癌组织中酸性富含半胱氨 酸分泌型蛋白的表达与生存的相关性[J]. 中华消化杂志, 2013, 33 (3): 197-8.]
|
| [7] |
Xue LY, Hu N, Song YM, et al. Tissue microarray analysis reveals a tight correlation between protein expression pattern and progression of esophageal squamous cell carcinoma[J]. BMC Cancer, 2006, 6: 296.
|
| [8] |
Porte H, Triboulet JP, Kotelevets L, et al. Overexpression of stromelysin-3, BM-40/SPARC, and MET genes in human esophageal carcinoma: implications for prognosis[J]. Clin Cancer Res, 1998, 4(6): 1375-82.
|
| [9] |
Tang L, Feng J. SPARC in tumor pathophysiology and as a potential therapeutic target[J]. Curr Pharm Des, 2014, 20(39): 61 82-90.
|
| [10] |
Derosa CA, Furusato B, Shaheduzzaman S, et al. Elevated osteonectin/SPARC expression in primary prostate cancer predicts metastatic progression[J]. Prostate Cancer Prostatic Dis, 2012, 15 (2): 150-6.
|
| [11] |
Miyoshi K, Sato N, Ohuchida K, et al. SPARC mRNA expression as a prognostic marker for pancreatic adenocarcinoma patients[J]. Anticancer Res, 2010, 30(3): 867-71.
|
| [12] |
Xue LY, Zou SM, Zheng S, et al. Expressions of the γ2 chain of laminin-5 and secreted protein acidic and rich in cysteine in esophageal squamous cell carcinoma and their relation to prognosis[J]. Chin J Cancer, 2011, 30(1): 69-78.
|
| [13] |
Thota R, Pauff JM, Berlin JD. Treatment of metastatic pancreatic adenocarcinoma: a review[J]. Oncology (Williston Park), 2014, 28 (1): 70-4.
|
下载:
